Category News

VectorY

VectorY Therapeutics Doses First Participant in Phase 1/2 PIONEER-ALS Trial of VTx-002 for ALS

VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been…

Read MoreVectorY Therapeutics Doses First Participant in Phase 1/2 PIONEER-ALS Trial of VTx-002 for ALS
ZCG-Backed

ZCG-Backed Unimed Completes Acquisition of Regenboog Shipping Pharmacy

ZCG-Backed Unimed Acquires Regenboog Shipping Pharmacy Universal Maritime Solutions a leading global provider of medical and compliance solutions to the maritime industry, today announced the acquisition of Regenboog Shipping Pharmacy, a Netherlands-based distributor of pharmaceutical products and medical devices serving the…

Read MoreZCG-Backed Unimed Completes Acquisition of Regenboog Shipping Pharmacy
Evinova

Evinova and Bristol Myers Squibb Partner Strategically to Enhance Clinical Development Using AI

Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of…

Read MoreEvinova and Bristol Myers Squibb Partner Strategically to Enhance Clinical Development Using AI
Johnson & Johnson

Johnson & Johnson Shares Early OMNY-AF Pilot Study Results at the 2026 AF Symposium

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation…

Read MoreJohnson & Johnson Shares Early OMNY-AF Pilot Study Results at the 2026 AF Symposium
DISTALS

Rapid Medical’s DISTALS Trial Shows Strong Results, Highlighting Superior Reperfusion with TIGERTRIEVER™ 13

Rapid Medical’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke Rapid Medical™, a leading developer of active endovascular devices, today announced late-breaking results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVER™ 13 achieved superior…

Read MoreRapid Medical’s DISTALS Trial Shows Strong Results, Highlighting Superior Reperfusion with TIGERTRIEVER™ 13
Supplemental

Supplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join

National Supplemental Screening Program Celebrates 20 Years of Service; Eligible Individuals Encouraged to Participate The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating 20 years of continued service and encourages those eligible to…

Read MoreSupplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join
Biotech Showcase

Biotech Showcase™ 2026 Highlighted Early-Stage Biotech Innovation During JPM Healthcare Week

Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology companies seeking meaningful visibility, strategic dialogue, and…

Read MoreBiotech Showcase™ 2026 Highlighted Early-Stage Biotech Innovation During JPM Healthcare Week
Magnus Medical

Magnus Medical Enrolls First Patient in DoD-Funded SAINT Postpartum Depression Study at UMass

Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing precision medicine in brain health, today announced enrollment of the first…

Read MoreMagnus Medical Enrolls First Patient in DoD-Funded SAINT Postpartum Depression Study at UMass